ŞENKARDEŞ, S. Et Al. 2017. Development and validation of a reversed-phase HPLC method for the determination of lisinopril and gliclazide in pharmaceuticals. MARMARA PHARMACEUTICAL JOURNAL , vol.21, no.2 , 338-344.

ŞENKARDEŞ, S., Ozaydin, T., UĞURLU, T., & KÜÇÜKGÜZEL, Ş. G., (2017). Development and validation of a reversed-phase HPLC method for the determination of lisinopril and gliclazide in pharmaceuticals. MARMARA PHARMACEUTICAL JOURNAL , vol.21, no.2, 338-344.

ŞENKARDEŞ, SEVİL Et Al. "Development and validation of a reversed-phase HPLC method for the determination of lisinopril and gliclazide in pharmaceuticals," MARMARA PHARMACEUTICAL JOURNAL , vol.21, no.2, 338-344, 2017

ŞENKARDEŞ, SEVİL Et Al. "Development and validation of a reversed-phase HPLC method for the determination of lisinopril and gliclazide in pharmaceuticals." MARMARA PHARMACEUTICAL JOURNAL , vol.21, no.2, pp.338-344, 2017

ŞENKARDEŞ, S. Et Al. (2017) . "Development and validation of a reversed-phase HPLC method for the determination of lisinopril and gliclazide in pharmaceuticals." MARMARA PHARMACEUTICAL JOURNAL , vol.21, no.2, pp.338-344.

@article{article, author={SEVİL ŞENKARDEŞ Et Al. }, title={Development and validation of a reversed-phase HPLC method for the determination of lisinopril and gliclazide in pharmaceuticals}, journal={MARMARA PHARMACEUTICAL JOURNAL}, year=2017, pages={338-344} }